Loading...

FITC Annexin V FITC Annexin V

Pricing & Availability
Regulatory Status
RUO
Other Names
Annexin A5, Dead, Apoptosis
Ave. Rating
Submit a Review
Product Citations
publications
AnnexinV_FITC_092908.jpg
Human T leukemia cell line, Jurkat, non-treated (top) or treated (bottom) with BioLegend’s anti-human CD95 (EOS9.1) mAb (cat. 305704) for 6 hours, then stained with Annexin V-FITC and Propidium Iodide (PI) (cat. 421301)
  • AnnexinV_FITC_092908.jpg
    Human T leukemia cell line, Jurkat, non-treated (top) or treated (bottom) with BioLegend’s anti-human CD95 (EOS9.1) mAb (cat. 305704) for 6 hours, then stained with Annexin V-FITC and Propidium Iodide (PI) (cat. 421301)
  • B_AnnexinV_FITC_092908.jpg
See FITC spectral data
Cat # Size Price Quantity Check Availability Save
640945 300 tests SEK3402
Check Availability


Need larger quantities of this item?
Request Bulk Quote
640906 100 tests SEK1630
Check Availability


Need larger quantities of this item?
Request Bulk Quote
640905 25 tests SEK698
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Annexin V (or Annexin A5) is a member of the annexin family of intracellular proteins that binds to phosphatidylserine (PS) in a calcium-dependent manner. PS is normally only found on the intracellular leaflet of the plasma membrane in healthy cells, but during early apoptosis, membrane asymmetry is lost and PS translocates to the external leaflet. Fluorochrome-labeled Annexin V can then be used to specifically target and identify apoptotic cells. Annexin V Binding Buffer (cat. no. 422201) is recommended for use with Annexin V staining.Annexin V binding alone cannot differentiate between apoptotic cells and necrotic. Therefore, we recommend using our Helix NP™ Blue (Cat. No. 425305), Helix NP™ Green (Cat.  No. 425303) or Helix NP™ NIR (Cat. No. 425301). Early apoptotic cells will exclude 7-AAD and PI, while late stage apoptotic cells and necrotic cells will stain positively, due to the passage of these dyes into the nucleus where they bind to DNA.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Human, Mouse, Rat
Reported Reactivity
Other Species
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation
The purified protein was conjugated with FITC under optimal conditions.
Concentration
Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The Annexin V solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this product is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per 100,000 - million cells in a 100 µl volume of Annexin V Binding Buffer (Cat No. 422201). It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Annexin V Staining

  1. Wash cells twice with cold BioLegend Cell Staining Buffer (Cat. No. 420201) and then resuspend cells in Annexin V Binding Buffer (Cat. No. 422201) at a concentration of 1x106 cells/mL.
  2. Transfer 100 µL of cell suspension in 5 mL test tube.
  3. Add 5 µL of fluorochrome conjugated Annexin V.
  4. Stain with a viability dye, such as PI (Cat. No. 421301), 7-AAD (Cat. Nos. 420403 & 420404), or Helix NP dyes (Cat. Nos. 425301, 425303, & 425305), if desired.
  5. Gently vortex the cells and incubate for 15 min at RT (25°C) in the dark.
  6. Add 400* µL of Annexin V Binding Buffer (Cat. No. 422201) to each tube. *For more concentrated samples, add a minimum of 200 µl of Annexin V Binding Buffer in this step.
  7. Analyze by flow cytometry.

For a better experience detecting apoptosis, we now recommend Apotracker™. Cell staining with Apotracker™ is Calcium independent. Thus, no special buffers are required, and the protocol can be shortened for single-step co-staining with other reagents.

Application References
  1. Koopman G, et al. 1994. Blood 84:1415.
  2. Vermes I, et al. 1995. J. Immunol. Methods 184:39.
  3. Dachary-Prigent J, et al. 1993. Blood 81:2554.
  4. Sekine C, et al. 2009. Int Immunol. PubMed
  5. Grujic M, et al. 2010. J. Immunol. 185:1730. PubMed
  6. Mulik RS, et al. 2010. Int J Pharm. 398:190. PubMed
  7. Gupta A, et al. 2011. Leuk Res. 35:1498. PubMed
  8. Speth C,et al. 2013. J Infect Dis. 207:823. PubMed
  9. Wang Q, et al. 2013. Genes Dev. 27:615. PubMed
  10. Gill K, et al. 2013. Biocheim Biophys Acta. 830:2763. PubMed
  11. Juel HB, et al. 2013. PLoS One. 8:64619. PubMed
  12. Hellmann J, et al. 2013. J. Immunol. 191:1383. PubMed
  13. Sequier S, et al. 2013. PLoS One. 8:70937. PubMed
  14. Galski H, et al. 2013. Biochem Pharmacol. 86:584. PubMed
  15. Chen YL, et al. 2013. J Exp Med. PubMed
  16. Lin WH, et al. 2014. PLoS One. 9:83160. PubMed
  17. Salge-Bartles U, 2014. Thromb res. 133:244. PubMed
  18. Zhang X, et al. 2014. Acta Biochim Biophys Sin. 46:261. PubMed
  19. Intermann J, et al. 2014. Cell Signal. 26:1567. PubMed
  20. de Vires M, 2014. Am J Physiol Lung Cell Mol Physiol. 307:240. PubMed
  21. M Parrula MC, et al. 2014. Virus Res. 189:206. PubMed
  22. Passaro C, et al. 2014. Mol Oncol. 9:78. PubMed
  23. Tsou WI, et al. 2014. J Biol Chem. 289:25750. PubMed
  24. Awojoodu AO, et al. 2014. Blood. 124:1941. PubMed
  25. Xiong R, et al. 2014. Toxicol Appl Pharmacol. 280:285. PubMed
  26. Liu J, et al. 2015. J Mol Cell Cardiol. 80:10. PubMed
Product Citations
  1. Yao Z, et al. 2018. J Virol. 92:00:00. PubMed
  2. Uriostegui–Arcos M, et al. 2020. Open Biol. 10:200050. PubMed
  3. Gallego-Murillo JS, et al. 2022. Biotechnol Bioeng. 119:3096. PubMed
  4. Du X, et al. 2023. Nucleic Acids Res. 51:1050. PubMed
  5. Vanoli F, et al. 2023. Oncogenesis. 12:8. PubMed
  6. Lei K, et al. 2023. iScience. 26:106001. PubMed
  7. Ohuchi K, et al. 2023. Biomed Rep. 18:28. PubMed
  8. Do-Thi VA, et al. 2023. Cancer Res Commun. 3:80. PubMed
  9. Perez GI, et al. 2023. Vaccines (Basel). 11:. PubMed
  10. Segaliny AI, et al. 2023. Commun Biol. 6:380. PubMed
  11. Potez M, et al. 2023. Front Oncol. 13:1124272. PubMed
  12. Woodley K, et al. 2023. Nat Commun. 14:2132. PubMed
  13. Quintela M, et al. 2023. Clin Epigenetics. 15:63. PubMed
  14. Quintela M, et al. 2023. Br J Cancer. . PubMed
  15. Zhang T, et al. 2022. EBioMedicine. 77:103872. PubMed
  16. Dhoonmoon A, et al. 2022. Nat Commun. 13:5063. PubMed
  17. Glynn RA, et al. 2022. J Immunol. 208:371. PubMed
  18. Cao H, et al. 2022. Br J Haematol. 198:155. PubMed
  19. Ugamraj HS, et al. 2022. MAbs. 14:2095949. PubMed
  20. Cao L, et al. 2022. Cell Rep. 40:111156. PubMed
  21. Choi UY, et al. 2022. Cell Rep. 40:111234. PubMed
  22. Kimmerling RJ, et al. 2022. Commun Biol. 5:1295. PubMed
  23. Chen X, et al. 2022. Front Pharmacol. 13:1028692. PubMed
  24. Shahid AM, et al. 2022. PLoS One. 17:e0278209. PubMed
  25. Önel T, et al. 2023. Naunyn Schmiedebergs Arch Pharmacol. :. PubMed
  26. Papakonstantinou A, et al. 2022. Int J Mol Sci. 24: . PubMed
  27. Li J, et al. 2023. J Biol Chem. 299:102875. PubMed
  28. Martinelli M, et al. 2023. iScience. 26:105860. PubMed
  29. Tay HG, et al. 2023. Mol Ther. 31:825. PubMed
  30. Dean BD, et al. 2023. J Immunother Cancer. 11: . PubMed
  31. Lieschke E, et al. 2022. Cell Death Differ. 29:1004. PubMed
  32. Zelenka T, et al. 2022. Nat Commun. 13:6954. PubMed
  33. Derudder E, et al. 2016. Proc Natl Acad Sci U S A. 113: 5065-5070. PubMed
  34. Bouhaddou M, et al. 2018. PLoS Comput Biol. 14:e1005985. PubMed
  35. Espinosa-Cueto P, et al. 2017. PLoS One.. 10.1371/journal.pone.0182126. PubMed
  36. Dowling CM, et al. 2021. Sci Adv. 7:. PubMed
  37. Lin YN, et al. 2022. Oncoimmunology. 11:2027136. PubMed
  38. Kim EH, et al. 2020. Elife. 9:00. PubMed
  39. Kitayama J, et al. 2016. PLoS One. 11: 0154542. PubMed
  40. Gedye C, et al. 2016. Sci Rep. 6: 25220. PubMed
  41. Carlsson J, et al. 2015. PLoS One. 10: 0143741. PubMed
  42. Yamauchi T et al. 2018. Cancer cell. 33(3):386-400 . PubMed
  43. Feng W, et al. 2017. Nat Commun. 0.697916667. PubMed
  44. Jones PD, et al. 2018. Arterioscler Thromb Vasc Biol. 38:1711. PubMed
  45. Lopes-Coelho F, et al. 2021. Front Oncol. 11:656229. PubMed
  46. Wang Q, et al. 2022. Nat Commun. 13:3022. PubMed
  47. Olelewe C, et al. 2022. iScience. 25:104340. PubMed
  48. Gupta A, et al. 2011. Leuk Res. 35:1498. PubMed
  49. Fujii T, et al. 2015. Proc Natl Acad Sci U S A. 112: 12800 - 12805. PubMed
  50. Cardoso B, et al. 2015. PLoS One. 10: 0143897. PubMed
  51. Alcon C, et al. 2020. Cell Death Dis. 0.898611111. PubMed
  52. Figueiredo T, et al. 2020. Mol Psychiatry. . PubMed
  53. Bowen ME, et al. 2019. Dev Cell. 50:212. PubMed
  54. Sales–Dias J, et al. 2019. PLoS One. 14:e0217002. PubMed
  55. Santos LC, et al. 2019. Nat Commun. 1.328472222. PubMed
  56. Lim JA, et al. 2018. BMC Cancer. 0.860416667. PubMed
  57. Venter C, et al. 2017. Cell Physiol Biochem. 43:1288. PubMed
  58. Kim Y, et al. 2020. J Neurochem. 155:177. PubMed
  59. Hassan MIA, et al. 2021. Comput Struct Biotechnol J. 19:880. PubMed
  60. Ramalingam P, et al. 2020. J Exp Med. 217:00:00. PubMed
  61. Karavasili C, et al. 2017. International Journal of Pharmaceutics. 10.1016/j.ijpharm.2017.05.061. PubMed
  62. Thompson PJ et al. 2019. Cell metabolism. 29(5):1045-1060 . PubMed
  63. Noguchi F, et al. 2017. Mol Cancer Ther. 1.316666667. PubMed
  64. Kumar S, et al. 2018. Cancers (Basel). 0.724305556. PubMed
  65. Fortin J, et al. 2020. Cancer Cell. 37:308. PubMed
  66. Vereertbrugghen A, et al. 2021. Front Oncol. 11:598319. PubMed
  67. Sun V, et al. 2021. Front Immunol. 12:716661. PubMed
  68. Coray M, et al. 2022. Int J Mol Sci. 23:. PubMed
  69. Soprano M, et al. 2016. PLoS One. 11: 0155970. PubMed
  70. Macpherson L, et al. 2020. Nature. 577:266. PubMed
  71. Chen MS, et al. 2019. Mol Cancer Res. 17:697. PubMed
  72. Ni F, et al. 2019. Cell Stem Cell. 24:608. PubMed
  73. Ning X, et al. 2019. Mol Cell. 74:19. PubMed
  74. Greenblatt SM, et al. 2018. Cancer Cell. 33:1111. PubMed
  75. Naqvi N,et al. 2017. Sci Rep.. 10.1038/s41598-017-12753-1. PubMed
  76. Wang M, et al. 2017. Biochemical and Biophysical Research Communications. 10.1016/j.bbrc.2017.05.097. PubMed
  77. Beeravolu N, McKee C, Chaudhry G 2017. J App Toxicol. 10.1002/jat.3469. PubMed
  78. Kim OV, et al. 2022. iScience. 25:104654. PubMed
  79. Shahzadi SK, et al. 2022. Clin Sci (Lond). 136:181. PubMed
  80. Kolbrink B, et al. 2022. Biochem J. 479:259. PubMed
  81. He C, et al. 2021. Oncoimmunology. 1897295:10. PubMed
  82. Pfalzgraff A, et al. 2016. Sci Rep. 6:31577. PubMed
  83. O'Neill K, et al. 2016. Genes Dev. 30: 973-988. PubMed
  84. Liu J, et al. 2015. J Mol Cell Cardiol. 80:10. PubMed
  85. Vries M, et al. 2014. Am J Physiol Lung Cell Mol Physiol. 307:240. PubMed
  86. Esteghamat F, et al. 2019. Nat Genet. 51:1233. PubMed
  87. Blümel E, et al. 2020. Oncoimmunology. 9:1751561. PubMed
  88. Sekine C, et al. 2009. Int Immunol. 1.079861111. PubMed
  89. Kinsella S, et al. 2021. Cell Rep. 37:109789. PubMed
  90. O'Connor MJ, et al. 2021. Oncogene. 40:4872. PubMed
  91. Parrula M, et al. 2014. Virus Res. 189:206. PubMed
  92. Brigger D, et al. 2015. Cell Death Dis. 6: e1861. PubMed
  93. Zhang J, et al. 2016. Cell Death Dis. 7:e2266. PubMed
  94. Wang D, et al. 2016. J Cell Sci. 129: 2261 - 2272. PubMed
  95. Uchtenhagen H, et al. 2016. Nat Commun. 7:12614. PubMed
  96. Geiger R, et al. 2016. Cell. 167:829-842. PubMed
  97. Rauzan M, et al. 2017. PLoS One. 12:e0174107. PubMed
  98. Liu Y, et al. 2017. Acta Biomater. 10.1016/j.actbio.2017.08.021. PubMed
  99. Chiani M, et al. 2017. Artif Cells Nanomed Biotechnol. 10.1080/21691401.2017.1337029. PubMed
  100. Yang L, et al. 2021. Cell Death Differ. 28:2616. PubMed
  101. Martín Monreal MT, et al. 2021. Front Immunol. 12:716250. PubMed
  102. Schmitz RL, et al. 2021. Cells. 10:. PubMed
  103. Babaei A, et al. 2021. Adv Pharm Bull. 11:361. PubMed
  104. Madala HR, et al. 2020. Cancer Res. 3492:80. PubMed
  105. Clements KE, et al. 2020. Nat Commun. 4.706944444. PubMed
  106. Kamiyama N, et al. 2017. Antiviral Res. 10.1016/j.antiviral.2017.08.007. PubMed
  107. Montero–Herradón S, et al. 2017. Organogenesis. 0.675. PubMed
  108. Nunes SC, et al. 2018. Sci Rep. 6.939583333. PubMed
  109. Sharif T, et al. 2018. Autophagy. 1.101388889. PubMed
  110. Eichelmann AK, et al. 2018. Sci Rep. 8:17553. PubMed
  111. Blümel E, et al. 2019. Oncoimmunology. 8:e1641387. PubMed
  112. Morimoto A, et al. 2021. Nat Commun. 12:2136. PubMed
  113. Norkin M, et al. 2021. Cell Rep. 35:109026. PubMed
  114. Krauss PL, et al. 2021. Front Immunol. 12:730672. PubMed
  115. Zhu Y, et al. 2022. Clin Transl Med. 12:e887. PubMed
  116. Khatib JB, et al. 2022. Oncotarget. 13:1078. PubMed
  117. Salge-Bartels U, et al. 2014. Thromb Res. 133:244. PubMed
  118. Passaro C, et al. 2014. Mol Oncol. 9:78. PubMed
  119. Ligtenberg M, et al. 2016. J Immunol. 196: 759 - 766. PubMed
  120. Hrdinka M, et al. 2016. PLoS One. 11: 0162863. PubMed
  121. Herold N, et al. 2017. Nat Med. 23:256-263. PubMed
  122. Xie S, et al. 2021. Sci Rep. 0.660416667. PubMed
  123. Müller I, et al. 2020. Mol Cell. 970:77. PubMed
  124. Liu H, et al. 2020. Cell Death Dis. 0.767361111. PubMed
  125. Zervou S, et al. 2017. PLoS One.. 10.1371/journal.pone.0182994. PubMed
  126. Ishidome T et al. 2017. EBioMedicine. 22:89-99 . PubMed
  127. Matsuda K, et al. 2021. Cell Rep Methods. 1:100122. PubMed
  128. Vanoli F, et al. 2021. Oncogene. 40:5095. PubMed
  129. Liu H, et al. 2021. J Immunother Cancer. 9:. PubMed
  130. Smith CM, et al. 2021. Biochem J. 478:3331. PubMed
  131. Li Y, et al. 2021. Sci Transl Med. 13:. PubMed
  132. Meyer N, et al. 2021. J Clin Med. 10:. PubMed
  133. Yoon Y, et al. 2016. Stem Cell Reports. 7:840-853. PubMed
  134. Chheda Z, et al. 2016. J Immunol. 197: 2016 - 2026. PubMed
  135. Slone E, et al. 2015. J Leukoc Biol. 98: 791 - 804. PubMed
  136. Séguier S, et al. 2013. PLoS One. 8:70937. PubMed
  137. Litzenburger UM, et al. 2017. Genome Biol. 18:15. PubMed
  138. Rajavel T, et al. 2017. Sci Rep. 2.665277778. PubMed
  139. Grujic M, et al. 2010. J Immunol. 185:1730. PubMed
  140. Gholamrezaei M, et al. 2021. Iran J Parasitol. 15:475. PubMed
  141. Meyer N, et al. 2021. Int J Mol Sci. 22:. PubMed
  142. Kolbrink B, et al. 2022. Cell Mol Life Sci. 79:387. PubMed
  143. Wang Q, et al. 2013. Genes Dev. 27:615. PubMed
  144. Douguet L, et al. 2016. PLoS One. 11:e0166164. PubMed
  145. Toutounchian J, et al. 2016. Mol Pharmacol. 91(1):1-13. PubMed
  146. Pajarillo E, et al. 2020. J Biol Chem. 295:3040. PubMed
  147. Matsumoto A, et al. 2019. J Extracell Vesicles. 9:1696517. PubMed
  148. Pirali T, et al. 2017. ChemMedChem. 1.570833333. PubMed
  149. Ishida M, et al. 2021. Int J Mol Sci. 22:. PubMed
  150. Lee DH, et al. 2020. Circ Res. 127:1182. PubMed
  151. Alsina-Sanchis E, et al. 2020. Mol Cancer Res. . PubMed
  152. L Chang, Y Li, D Kaplan 2016. Sci Rep. 6:36862. PubMed
  153. Becker A, et al. 2016. Sci Rep. 6: 33847. PubMed
  154. Kumai T, et al. 2015. Sci Rep. 5:16280. PubMed
  155. Polak R, et al. 2015. Blood. 126: 2404 - 2414. PubMed
  156. Hafez A, et al. 2017. Oncogenesis. 10.1038/oncsis.2017.46. PubMed
  157. Putheti P, et al. 2010. PLoS One. 5:e8706. PubMed
  158. Nastasi C, et al. 2021. Sci Rep. 11:1458. PubMed
  159. Molinar-Inglis O, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  160. Erdogan M, et al. 2022. Chem Biodivers. 19:e202200659. PubMed
  161. Galski H, et al. 2013. Biochem Pharmacol. 86:584. PubMed
  162. Tsou W, et al. 2014. J Biol Chem. 289:25750. PubMed
  163. Dhoonmoon A, et al. 2020. Nucleic Acids Res. 48:7252. PubMed
  164. Gladow N, et al. 2020. PLoS One. 15:e0227734. PubMed
  165. Lee HW, et al. 2018. Am J Physiol Renal Physiol. 314:F280. PubMed
  166. Ki H, et al. 2017. Biomed Pharmacother. 10.1016/j.biopha.2017.09.118. PubMed
  167. Shadboorestan A, et al. 2022. Iran J Basic Med Sci. 25:506. PubMed
  168. Huang Y, et al. 2022. Front Cell Dev Biol. 9:837777. PubMed
  169. Babaei A, et al. 2020. Daru. 28:555. PubMed
  170. King R, et al. 2021. Sci Adv. 7:eabj5293. PubMed
  171. Cai Z, et al. 2020. Cell Rep. 31:107816. PubMed
  172. Liu B, et al. 2016. J Biol Chem. 291: 23869 - 23881. PubMed
  173. Lhuillier C, et al. 2015. J Biol Chem. 290: 16797 - 16811. PubMed
  174. Passaro C, et al. 2013. Endocr Relat Cancer. 20:633. PubMed
  175. Mulik R, et al. 2010. Int J Pharm. 398:190. PubMed
  176. Speth C, et al. 2013. J Infect Dis. 207:823. PubMed
  177. Schuler F, et al. 2017. Nat Commun. . 10.1038/s41467-017-01850-4. PubMed
  178. Di Somma S, et al. 2019. Cancers (Basel). 1.70625. PubMed
  179. Abu El Maaty MA, et al. 2021. Sci Adv. 7: . PubMed
  180. Bahl S, et al. 2021. Cell Death Dis. 12:469. PubMed
  181. Jackson LM, et al. 2021. Nucleic Acids Res. 49:12855. PubMed
  182. Lin W, et al. 2014. PLoS One. 9:83160. PubMed
  183. Zhang X, et al. 2014. Acta Biochim Biophys Sin. 46:261. PubMed
  184. CO L, et al. 2015. Nat Commun. 6: 7739. PubMed
  185. Huang YL, et al. 2020. Elife. 9:00. PubMed
  186. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  187. Fang P, et al. 2019. Commun Biol. 0.315972222. PubMed
  188. Kumar S, et al. 2019. Int J Cancer. 146:1652. PubMed
  189. Zhao CC, et al. 2018. Oncol Rep. 40:3392. PubMed
  190. Schleicher EM, et al. 2018. Nucleic Acids Res. 46:8908. PubMed
  191. Thomas A, et al. 2017. PLoS One.. 10.1371/journal.pone.0183542. PubMed
  192. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  193. Alcon C, et al. 2021. Cells. 10:. PubMed
  194. Cao H, et al. 2021. Nat Commun. 12:1792. PubMed
  195. Faria M, et al. 2017. PLoS One. 12(2):e0172689. PubMed
  196. Jones P, et al. 2016. J Biol Chem. 291: 16318 - 16327. PubMed
  197. Awojoodu A, et al. 2014. Blood. 124:1941. PubMed
  198. Intemann J, et al. 2014. Cell Signal. 26:1567. PubMed
  199. Clements KE, et al. 2018. Nucleic Acids Res. 46:8898. PubMed
  200. Bostanabad SY, et al. 2021. Sci Rep. 11:1539. PubMed
  201. Monzen S, et al. 2022. Mol Clin Oncol. 16:19. PubMed
  202. Konda P, et al. 2022. Am J Cancer Res. 12:210. PubMed
  203. Wu J, et al. 2021. Adv Sci (Weinh). 8:e2101029. PubMed
  204. Mendès C, et al. 2019. Sci Rep. 9:14107. PubMed
  205. Lopes–Coelho F, et al. 2017. Oncotarget. 8:82803. PubMed
  206. Lu Y, et al. 2018. Cancer Cell. 33:1048. PubMed
  207. Thanuthanakhun N, et al. 2017. PLoS One. . 10.1371/journal.pone.0187610. PubMed
  208. Kuntz E, et al. 2017. Nat Med. 10.1038/nm.4399. PubMed
  209. Tu Z, et al. 2022. Cell Rep. 40:111072. PubMed
  210. Bensberg M, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  211. Paparella AS, et al. 2021. Nat Commun. 12:6285. PubMed
  212. Huang YL, et al. 2021. iScience. 24:103168. PubMed
  213. Zhang Y, et al. 2021. Cell Death Dis. 0.563194444. PubMed
  214. Kang JH, et al. 2020. Cell Death Dis. 0.803472222. PubMed
  215. Dewdney B, et al. 2020. Sci Rep. 10:16769. PubMed
  216. Simoni L, et al. 2020. Cell Rep. 33:108330. PubMed
  217. Coutaz M, et al. 2016. Sci Rep. 6:39117. PubMed
  218. Akane K, et al. 2016. Proc Natl Acad Sci U S A. 113: 2460 - 2465. PubMed
  219. Xiong R, et al. 2014. Toxicol Appl Pharmacol. 280:285. PubMed
  220. Chen Y, et al. 2013. J Exp Med. 210:2515. PubMed
  221. Siddhartha V, et al. 2017. Artif Cells Nanomed Biotechnol . 10.1080/21691401.2017.1313267. PubMed
  222. He J, et al. 2017. FASEB J. 31:2893. PubMed
  223. Lyu X, et al. 2019. BMC Genomics. 1.235416667. PubMed
  224. Jing Y, et al. 2019. J Allergy Clin Immunol. 144:1377. PubMed
  225. Quan M, et al. 2019. Oncol Rep. 41:3051. PubMed
  226. Kasikara C, et al. 2021. J Clin Invest. 131:. PubMed
  227. Ning N, et al. 2022. Theranostics. 12:5537. PubMed
  228. Bottardi S, et al. 2020. Exp Hematol. 68:88. PubMed
  229. Young MM, et al. 2019. Cell Death Dis. 1.004861111. PubMed
  230. Santos I, et al. 2019. Nutrients. 2.210416667. PubMed
  231. Vancsik T, et al. 2019. Cancer Med. 3.313888889. PubMed
  232. Zheng M, et al. 2019. Proc Natl Acad Sci U S A. 116:12422. PubMed
  233. Zheng Q, et al. 2017. Mol Oncol. 10.1002/1878-0261.12056. PubMed
  234. Wang Y, et al. 2022. Front Cardiovasc Med. 9:876087. PubMed
  235. Shankman LS, et al. 2021. Curr Biol. 31:2469. PubMed
  236. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
  237. Pahari S, et al. 2020. Autophagy. 1.375694444. PubMed
  238. Schleicher EM, et al. 2020. PLoS Genet. 16:e1009176. PubMed
  239. Langsch S, et al. 2016. Cancer Res . 76: 4160 - 4169. PubMed
  240. Xiong R, et al. 2015. Mol Pharmacol. 88: 1045 - 1054. PubMed
  241. Hellmann J, et al. 2013. J Immunol. 191:1383. PubMed
  242. Juel H, et al. 2013. PLoS One. 8:64619. PubMed
  243. Gill K, et al. 2013. Biochim Biophys Acta. 1830:2763. PubMed
  244. Yao Z, et al. 2018. J Virol. 92:00:00. PubMed
  245. Uriostegui–Arcos M, et al. 2020. Open Biol. 10:200050. PubMed
  246. Gallego-Murillo JS, et al. 2022. Biotechnol Bioeng. 119:3096. PubMed
  247. Du X, et al. 2023. Nucleic Acids Res. 51:1050. PubMed
  248. Vanoli F, et al. 2023. Oncogenesis. 12:8. PubMed
  249. Lei K, et al. 2023. iScience. 26:106001. PubMed
  250. Ohuchi K, et al. 2023. Biomed Rep. 18:28. PubMed
  251. Do-Thi VA, et al. 2023. Cancer Res Commun. 3:80. PubMed
  252. Perez GI, et al. 2023. Vaccines (Basel). 11:. PubMed
  253. Segaliny AI, et al. 2023. Commun Biol. 6:380. PubMed
  254. Potez M, et al. 2023. Front Oncol. 13:1124272. PubMed
  255. Woodley K, et al. 2023. Nat Commun. 14:2132. PubMed
  256. Quintela M, et al. 2023. Clin Epigenetics. 15:63. PubMed
  257. Quintela M, et al. 2023. Br J Cancer. . PubMed
  258. Zhang T, et al. 2022. EBioMedicine. 77:103872. PubMed
  259. Dhoonmoon A, et al. 2022. Nat Commun. 13:5063. PubMed
  260. Glynn RA, et al. 2022. J Immunol. 208:371. PubMed
  261. Cao H, et al. 2022. Br J Haematol. 198:155. PubMed
  262. Ugamraj HS, et al. 2022. MAbs. 14:2095949. PubMed
  263. Cao L, et al. 2022. Cell Rep. 40:111156. PubMed
  264. Choi UY, et al. 2022. Cell Rep. 40:111234. PubMed
  265. Kimmerling RJ, et al. 2022. Commun Biol. 5:1295. PubMed
  266. Chen X, et al. 2022. Front Pharmacol. 13:1028692. PubMed
  267. Shahid AM, et al. 2022. PLoS One. 17:e0278209. PubMed
  268. Önel T, et al. 2023. Naunyn Schmiedebergs Arch Pharmacol. :. PubMed
  269. Papakonstantinou A, et al. 2022. Int J Mol Sci. 24: . PubMed
  270. Li J, et al. 2023. J Biol Chem. 299:102875. PubMed
  271. Martinelli M, et al. 2023. iScience. 26:105860. PubMed
  272. Tay HG, et al. 2023. Mol Ther. 31:825. PubMed
  273. Dean BD, et al. 2023. J Immunother Cancer. 11: . PubMed
  274. Lieschke E, et al. 2022. Cell Death Differ. 29:1004. PubMed
  275. Zelenka T, et al. 2022. Nat Commun. 13:6954. PubMed
  276. Derudder E, et al. 2016. Proc Natl Acad Sci U S A. 113: 5065-5070. PubMed
  277. Bouhaddou M, et al. 2018. PLoS Comput Biol. 14:e1005985. PubMed
  278. Espinosa-Cueto P, et al. 2017. PLoS One.. 10.1371/journal.pone.0182126. PubMed
  279. Dowling CM, et al. 2021. Sci Adv. 7:. PubMed
  280. Lin YN, et al. 2022. Oncoimmunology. 11:2027136. PubMed
  281. Kim EH, et al. 2020. Elife. 9:00. PubMed
  282. Kitayama J, et al. 2016. PLoS One. 11: 0154542. PubMed
  283. Gedye C, et al. 2016. Sci Rep. 6: 25220. PubMed
  284. Carlsson J, et al. 2015. PLoS One. 10: 0143741. PubMed
  285. Yamauchi T et al. 2018. Cancer cell. 33(3):386-400 . PubMed
  286. Feng W, et al. 2017. Nat Commun. 0.697916667. PubMed
  287. Jones PD, et al. 2018. Arterioscler Thromb Vasc Biol. 38:1711. PubMed
  288. Lopes-Coelho F, et al. 2021. Front Oncol. 11:656229. PubMed
  289. Wang Q, et al. 2022. Nat Commun. 13:3022. PubMed
  290. Olelewe C, et al. 2022. iScience. 25:104340. PubMed
  291. Gupta A, et al. 2011. Leuk Res. 35:1498. PubMed
  292. Fujii T, et al. 2015. Proc Natl Acad Sci U S A. 112: 12800 - 12805. PubMed
  293. Cardoso B, et al. 2015. PLoS One. 10: 0143897. PubMed
  294. Alcon C, et al. 2020. Cell Death Dis. 0.898611111. PubMed
  295. Figueiredo T, et al. 2020. Mol Psychiatry. . PubMed
  296. Bowen ME, et al. 2019. Dev Cell. 50:212. PubMed
  297. Sales–Dias J, et al. 2019. PLoS One. 14:e0217002. PubMed
  298. Santos LC, et al. 2019. Nat Commun. 1.328472222. PubMed
  299. Lim JA, et al. 2018. BMC Cancer. 0.860416667. PubMed
  300. Venter C, et al. 2017. Cell Physiol Biochem. 43:1288. PubMed
  301. Kim Y, et al. 2020. J Neurochem. 155:177. PubMed
  302. Hassan MIA, et al. 2021. Comput Struct Biotechnol J. 19:880. PubMed
  303. Ramalingam P, et al. 2020. J Exp Med. 217:00:00. PubMed
  304. Karavasili C, et al. 2017. International Journal of Pharmaceutics. 10.1016/j.ijpharm.2017.05.061. PubMed
  305. Thompson PJ et al. 2019. Cell metabolism. 29(5):1045-1060 . PubMed
  306. Noguchi F, et al. 2017. Mol Cancer Ther. 1.316666667. PubMed
  307. Kumar S, et al. 2018. Cancers (Basel). 0.724305556. PubMed
  308. Fortin J, et al. 2020. Cancer Cell. 37:308. PubMed
  309. Vereertbrugghen A, et al. 2021. Front Oncol. 11:598319. PubMed
  310. Sun V, et al. 2021. Front Immunol. 12:716661. PubMed
  311. Coray M, et al. 2022. Int J Mol Sci. 23:. PubMed
  312. Soprano M, et al. 2016. PLoS One. 11: 0155970. PubMed
  313. Macpherson L, et al. 2020. Nature. 577:266. PubMed
  314. Chen MS, et al. 2019. Mol Cancer Res. 17:697. PubMed
  315. Ni F, et al. 2019. Cell Stem Cell. 24:608. PubMed
  316. Ning X, et al. 2019. Mol Cell. 74:19. PubMed
  317. Greenblatt SM, et al. 2018. Cancer Cell. 33:1111. PubMed
  318. Naqvi N,et al. 2017. Sci Rep.. 10.1038/s41598-017-12753-1. PubMed
  319. Wang M, et al. 2017. Biochemical and Biophysical Research Communications. 10.1016/j.bbrc.2017.05.097. PubMed
  320. Beeravolu N, McKee C, Chaudhry G 2017. J App Toxicol. 10.1002/jat.3469. PubMed
  321. Kim OV, et al. 2022. iScience. 25:104654. PubMed
  322. Shahzadi SK, et al. 2022. Clin Sci (Lond). 136:181. PubMed
  323. Kolbrink B, et al. 2022. Biochem J. 479:259. PubMed
  324. He C, et al. 2021. Oncoimmunology. 1897295:10. PubMed
  325. Pfalzgraff A, et al. 2016. Sci Rep. 6:31577. PubMed
  326. O'Neill K, et al. 2016. Genes Dev. 30: 973-988. PubMed
  327. Liu J, et al. 2015. J Mol Cell Cardiol. 80:10. PubMed
  328. Vries M, et al. 2014. Am J Physiol Lung Cell Mol Physiol. 307:240. PubMed
  329. Esteghamat F, et al. 2019. Nat Genet. 51:1233. PubMed
  330. Blümel E, et al. 2020. Oncoimmunology. 9:1751561. PubMed
  331. Sekine C, et al. 2009. Int Immunol. 1.079861111. PubMed
  332. Kinsella S, et al. 2021. Cell Rep. 37:109789. PubMed
  333. O'Connor MJ, et al. 2021. Oncogene. 40:4872. PubMed
  334. Parrula M, et al. 2014. Virus Res. 189:206. PubMed
  335. Brigger D, et al. 2015. Cell Death Dis. 6: e1861. PubMed
  336. Zhang J, et al. 2016. Cell Death Dis. 7:e2266. PubMed
  337. Wang D, et al. 2016. J Cell Sci. 129: 2261 - 2272. PubMed
  338. Uchtenhagen H, et al. 2016. Nat Commun. 7:12614. PubMed
  339. Geiger R, et al. 2016. Cell. 167:829-842. PubMed
  340. Rauzan M, et al. 2017. PLoS One. 12:e0174107. PubMed
  341. Liu Y, et al. 2017. Acta Biomater. 10.1016/j.actbio.2017.08.021. PubMed
  342. Chiani M, et al. 2017. Artif Cells Nanomed Biotechnol. 10.1080/21691401.2017.1337029. PubMed
  343. Yang L, et al. 2021. Cell Death Differ. 28:2616. PubMed
  344. Martín Monreal MT, et al. 2021. Front Immunol. 12:716250. PubMed
  345. Schmitz RL, et al. 2021. Cells. 10:. PubMed
  346. Babaei A, et al. 2021. Adv Pharm Bull. 11:361. PubMed
  347. Madala HR, et al. 2020. Cancer Res. 3492:80. PubMed
  348. Clements KE, et al. 2020. Nat Commun. 4.706944444. PubMed
  349. Kamiyama N, et al. 2017. Antiviral Res. 10.1016/j.antiviral.2017.08.007. PubMed
  350. Montero–Herradón S, et al. 2017. Organogenesis. 0.675. PubMed
  351. Nunes SC, et al. 2018. Sci Rep. 6.939583333. PubMed
  352. Sharif T, et al. 2018. Autophagy. 1.101388889. PubMed
  353. Eichelmann AK, et al. 2018. Sci Rep. 8:17553. PubMed
  354. Blümel E, et al. 2019. Oncoimmunology. 8:e1641387. PubMed
  355. Morimoto A, et al. 2021. Nat Commun. 12:2136. PubMed
  356. Norkin M, et al. 2021. Cell Rep. 35:109026. PubMed
  357. Krauss PL, et al. 2021. Front Immunol. 12:730672. PubMed
  358. Zhu Y, et al. 2022. Clin Transl Med. 12:e887. PubMed
  359. Khatib JB, et al. 2022. Oncotarget. 13:1078. PubMed
  360. Salge-Bartels U, et al. 2014. Thromb Res. 133:244. PubMed
  361. Passaro C, et al. 2014. Mol Oncol. 9:78. PubMed
  362. Ligtenberg M, et al. 2016. J Immunol. 196: 759 - 766. PubMed
  363. Hrdinka M, et al. 2016. PLoS One. 11: 0162863. PubMed
  364. Herold N, et al. 2017. Nat Med. 23:256-263. PubMed
  365. Xie S, et al. 2021. Sci Rep. 0.660416667. PubMed
  366. Müller I, et al. 2020. Mol Cell. 970:77. PubMed
  367. Liu H, et al. 2020. Cell Death Dis. 0.767361111. PubMed
  368. Zervou S, et al. 2017. PLoS One.. 10.1371/journal.pone.0182994. PubMed
  369. Ishidome T et al. 2017. EBioMedicine. 22:89-99 . PubMed
  370. Matsuda K, et al. 2021. Cell Rep Methods. 1:100122. PubMed
  371. Vanoli F, et al. 2021. Oncogene. 40:5095. PubMed
  372. Liu H, et al. 2021. J Immunother Cancer. 9:. PubMed
  373. Smith CM, et al. 2021. Biochem J. 478:3331. PubMed
  374. Li Y, et al. 2021. Sci Transl Med. 13:. PubMed
  375. Meyer N, et al. 2021. J Clin Med. 10:. PubMed
  376. Yoon Y, et al. 2016. Stem Cell Reports. 7:840-853. PubMed
  377. Chheda Z, et al. 2016. J Immunol. 197: 2016 - 2026. PubMed
  378. Slone E, et al. 2015. J Leukoc Biol. 98: 791 - 804. PubMed
  379. Séguier S, et al. 2013. PLoS One. 8:70937. PubMed
  380. Litzenburger UM, et al. 2017. Genome Biol. 18:15. PubMed
  381. Rajavel T, et al. 2017. Sci Rep. 2.665277778. PubMed
  382. Grujic M, et al. 2010. J Immunol. 185:1730. PubMed
  383. Gholamrezaei M, et al. 2021. Iran J Parasitol. 15:475. PubMed
  384. Meyer N, et al. 2021. Int J Mol Sci. 22:. PubMed
  385. Kolbrink B, et al. 2022. Cell Mol Life Sci. 79:387. PubMed
  386. Wang Q, et al. 2013. Genes Dev. 27:615. PubMed
  387. Douguet L, et al. 2016. PLoS One. 11:e0166164. PubMed
  388. Toutounchian J, et al. 2016. Mol Pharmacol. 91(1):1-13. PubMed
  389. Pajarillo E, et al. 2020. J Biol Chem. 295:3040. PubMed
  390. Matsumoto A, et al. 2019. J Extracell Vesicles. 9:1696517. PubMed
  391. Pirali T, et al. 2017. ChemMedChem. 1.570833333. PubMed
  392. Ishida M, et al. 2021. Int J Mol Sci. 22:. PubMed
  393. Lee DH, et al. 2020. Circ Res. 127:1182. PubMed
  394. Alsina-Sanchis E, et al. 2020. Mol Cancer Res. . PubMed
  395. L Chang, Y Li, D Kaplan 2016. Sci Rep. 6:36862. PubMed
  396. Becker A, et al. 2016. Sci Rep. 6: 33847. PubMed
  397. Kumai T, et al. 2015. Sci Rep. 5:16280. PubMed
  398. Polak R, et al. 2015. Blood. 126: 2404 - 2414. PubMed
  399. Hafez A, et al. 2017. Oncogenesis. 10.1038/oncsis.2017.46. PubMed
  400. Putheti P, et al. 2010. PLoS One. 5:e8706. PubMed
  401. Nastasi C, et al. 2021. Sci Rep. 11:1458. PubMed
  402. Molinar-Inglis O, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  403. Erdogan M, et al. 2022. Chem Biodivers. 19:e202200659. PubMed
  404. Galski H, et al. 2013. Biochem Pharmacol. 86:584. PubMed
  405. Tsou W, et al. 2014. J Biol Chem. 289:25750. PubMed
  406. Dhoonmoon A, et al. 2020. Nucleic Acids Res. 48:7252. PubMed
  407. Gladow N, et al. 2020. PLoS One. 15:e0227734. PubMed
  408. Lee HW, et al. 2018. Am J Physiol Renal Physiol. 314:F280. PubMed
  409. Ki H, et al. 2017. Biomed Pharmacother. 10.1016/j.biopha.2017.09.118. PubMed
  410. Shadboorestan A, et al. 2022. Iran J Basic Med Sci. 25:506. PubMed
  411. Huang Y, et al. 2022. Front Cell Dev Biol. 9:837777. PubMed
  412. Babaei A, et al. 2020. Daru. 28:555. PubMed
  413. King R, et al. 2021. Sci Adv. 7:eabj5293. PubMed
  414. Cai Z, et al. 2020. Cell Rep. 31:107816. PubMed
  415. Liu B, et al. 2016. J Biol Chem. 291: 23869 - 23881. PubMed
  416. Lhuillier C, et al. 2015. J Biol Chem. 290: 16797 - 16811. PubMed
  417. Passaro C, et al. 2013. Endocr Relat Cancer. 20:633. PubMed
  418. Mulik R, et al. 2010. Int J Pharm. 398:190. PubMed
  419. Speth C, et al. 2013. J Infect Dis. 207:823. PubMed
  420. Schuler F, et al. 2017. Nat Commun. . 10.1038/s41467-017-01850-4. PubMed
  421. Di Somma S, et al. 2019. Cancers (Basel). 1.70625. PubMed
  422. Abu El Maaty MA, et al. 2021. Sci Adv. 7: . PubMed
  423. Bahl S, et al. 2021. Cell Death Dis. 12:469. PubMed
  424. Jackson LM, et al. 2021. Nucleic Acids Res. 49:12855. PubMed
  425. Lin W, et al. 2014. PLoS One. 9:83160. PubMed
  426. Zhang X, et al. 2014. Acta Biochim Biophys Sin. 46:261. PubMed
  427. CO L, et al. 2015. Nat Commun. 6: 7739. PubMed
  428. Huang YL, et al. 2020. Elife. 9:00. PubMed
  429. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  430. Fang P, et al. 2019. Commun Biol. 0.315972222. PubMed
  431. Kumar S, et al. 2019. Int J Cancer. 146:1652. PubMed
  432. Zhao CC, et al. 2018. Oncol Rep. 40:3392. PubMed
  433. Schleicher EM, et al. 2018. Nucleic Acids Res. 46:8908. PubMed
  434. Thomas A, et al. 2017. PLoS One.. 10.1371/journal.pone.0183542. PubMed
  435. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  436. Alcon C, et al. 2021. Cells. 10:. PubMed
  437. Cao H, et al. 2021. Nat Commun. 12:1792. PubMed
  438. Faria M, et al. 2017. PLoS One. 12(2):e0172689. PubMed
  439. Jones P, et al. 2016. J Biol Chem. 291: 16318 - 16327. PubMed
  440. Awojoodu A, et al. 2014. Blood. 124:1941. PubMed
  441. Intemann J, et al. 2014. Cell Signal. 26:1567. PubMed
  442. Clements KE, et al. 2018. Nucleic Acids Res. 46:8898. PubMed
  443. Bostanabad SY, et al. 2021. Sci Rep. 11:1539. PubMed
  444. Monzen S, et al. 2022. Mol Clin Oncol. 16:19. PubMed
  445. Konda P, et al. 2022. Am J Cancer Res. 12:210. PubMed
  446. Wu J, et al. 2021. Adv Sci (Weinh). 8:e2101029. PubMed
  447. Mendès C, et al. 2019. Sci Rep. 9:14107. PubMed
  448. Lopes–Coelho F, et al. 2017. Oncotarget. 8:82803. PubMed
  449. Lu Y, et al. 2018. Cancer Cell. 33:1048. PubMed
  450. Thanuthanakhun N, et al. 2017. PLoS One. . 10.1371/journal.pone.0187610. PubMed
  451. Kuntz E, et al. 2017. Nat Med. 10.1038/nm.4399. PubMed
  452. Tu Z, et al. 2022. Cell Rep. 40:111072. PubMed
  453. Bensberg M, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  454. Paparella AS, et al. 2021. Nat Commun. 12:6285. PubMed
  455. Huang YL, et al. 2021. iScience. 24:103168. PubMed
  456. Zhang Y, et al. 2021. Cell Death Dis. 0.563194444. PubMed
  457. Kang JH, et al. 2020. Cell Death Dis. 0.803472222. PubMed
  458. Dewdney B, et al. 2020. Sci Rep. 10:16769. PubMed
  459. Simoni L, et al. 2020. Cell Rep. 33:108330. PubMed
  460. Coutaz M, et al. 2016. Sci Rep. 6:39117. PubMed
  461. Akane K, et al. 2016. Proc Natl Acad Sci U S A. 113: 2460 - 2465. PubMed
  462. Xiong R, et al. 2014. Toxicol Appl Pharmacol. 280:285. PubMed
  463. Chen Y, et al. 2013. J Exp Med. 210:2515. PubMed
  464. Siddhartha V, et al. 2017. Artif Cells Nanomed Biotechnol . 10.1080/21691401.2017.1313267. PubMed
  465. He J, et al. 2017. FASEB J. 31:2893. PubMed
  466. Lyu X, et al. 2019. BMC Genomics. 1.235416667. PubMed
  467. Jing Y, et al. 2019. J Allergy Clin Immunol. 144:1377. PubMed
  468. Quan M, et al. 2019. Oncol Rep. 41:3051. PubMed
  469. Kasikara C, et al. 2021. J Clin Invest. 131:. PubMed
  470. Ning N, et al. 2022. Theranostics. 12:5537. PubMed
  471. Bottardi S, et al. 2020. Exp Hematol. 68:88. PubMed
  472. Young MM, et al. 2019. Cell Death Dis. 1.004861111. PubMed
  473. Santos I, et al. 2019. Nutrients. 2.210416667. PubMed
  474. Vancsik T, et al. 2019. Cancer Med. 3.313888889. PubMed
  475. Zheng M, et al. 2019. Proc Natl Acad Sci U S A. 116:12422. PubMed
  476. Zheng Q, et al. 2017. Mol Oncol. 10.1002/1878-0261.12056. PubMed
  477. Wang Y, et al. 2022. Front Cardiovasc Med. 9:876087. PubMed
  478. Shankman LS, et al. 2021. Curr Biol. 31:2469. PubMed
  479. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
  480. Pahari S, et al. 2020. Autophagy. 1.375694444. PubMed
  481. Schleicher EM, et al. 2020. PLoS Genet. 16:e1009176. PubMed
  482. Langsch S, et al. 2016. Cancer Res . 76: 4160 - 4169. PubMed
  483. Xiong R, et al. 2015. Mol Pharmacol. 88: 1045 - 1054. PubMed
  484. Hellmann J, et al. 2013. J Immunol. 191:1383. PubMed
  485. Juel H, et al. 2013. PLoS One. 8:64619. PubMed
  486. Gill K, et al. 2013. Biochim Biophys Acta. 1830:2763. PubMed
RRID
AB_2629519 (BioLegend Cat. No. 640945)
AB_2561292 (BioLegend Cat. No. 640906)
AB_2561291 (BioLegend Cat. No. 640905)

Antigen Details

Biology Area
Apoptosis/Tumor Suppressors/Cell Death, Cell Biology, Neuroscience
Gene ID
308 View all products for this Gene ID
UniProt
View information about Annexin V on UniProt.org

Related FAQs

How is your Annexin made and what sequence does it cover?

It is made in E. coli, covering human aa Met1-Asp320.

How does pH and staining temperature affect Annexin V-Phosphatidylserine binding?

Annexin-Phosphatidylserine binding is lost below pH 5.2 and with prolonged incubation over a temperature of 42°C.

Why do I need to use Annexin V Binding Buffer?

Annexin V binding requires the presence of calcium in the solution.  So, we provide Annexin V Binding Buffer (cat # 422201), which is optimized for the best performance of Annexin V staining.

Can I use RPMI during Annexin V staining?

It is best to follow protocol as described on the product data sheet. Moreover, RPMI 1640 has a relatively high concentration of phosphate and low calcium ion concentration, which negatively impacts Annexin binding to its target phosphatidylserine (PS). Measurement of cell death by using Annexin V may also be significantly affected by time of incubation on ice, calcium concentration, and type of medium.

Can I freeze Annexin V conjugates?

It should not be frozen as it will lead to loss of biological activity due to dimerization.

Is Annexin V suitable for conjugation with the Maxpar® kit for CyTOF®?

Maxpar® Labeling kits require the protein to be partially reduced, so the metal chelate can be introduced through an SH group in the hinge region of the reduced antibody. Human Annexin V contains only one Cysteine which was reported to be chemically inactive. Thus, the Maxpar® labeling protocol would not work with Annexin V, unless a free –SH group can be introduced to Annexin V.  For more information regarding SH-mediated conjugation of Annexin V please consult published papers such as this one.

Go To Top Version: 7    Revision Date: 10-22-2024

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Regulatory Status
RUO
Other Names
Annexin A5, Dead, Apoptosis
Ave. Rating
Submit a Review
Product Citations
publications
AnnexinV_FITC_092908.jpg
Human T leukemia cell line, Jurkat, non-treated (top) or treated (bottom) with BioLegend’s anti-human CD95 (EOS9.1) mAb (cat. 305704) for 6 hours, then stained with Annexin V-FITC and Propidium Iodide (PI) (cat. 421301)
  • AnnexinV_FITC_092908.jpg
    Human T leukemia cell line, Jurkat, non-treated (top) or treated (bottom) with BioLegend’s anti-human CD95 (EOS9.1) mAb (cat. 305704) for 6 hours, then stained with Annexin V-FITC and Propidium Iodide (PI) (cat. 421301)
  • B_AnnexinV_FITC_092908.jpg
See FITC spectral data
Cat # Size Price Quantity Check Availability Save
640945 300 tests SEK3402
Check Availability


Need larger quantities of this item?
Request Bulk Quote
640906 100 tests SEK1630
Check Availability


Need larger quantities of this item?
Request Bulk Quote
640905 25 tests SEK698
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Annexin V (or Annexin A5) is a member of the annexin family of intracellular proteins that binds to phosphatidylserine (PS) in a calcium-dependent manner. PS is normally only found on the intracellular leaflet of the plasma membrane in healthy cells, but during early apoptosis, membrane asymmetry is lost and PS translocates to the external leaflet. Fluorochrome-labeled Annexin V can then be used to specifically target and identify apoptotic cells. Annexin V Binding Buffer (cat. no. 422201) is recommended for use with Annexin V staining.Annexin V binding alone cannot differentiate between apoptotic cells and necrotic. Therefore, we recommend using our Helix NP™ Blue (Cat. No. 425305), Helix NP™ Green (Cat.  No. 425303) or Helix NP™ NIR (Cat. No. 425301). Early apoptotic cells will exclude 7-AAD and PI, while late stage apoptotic cells and necrotic cells will stain positively, due to the passage of these dyes into the nucleus where they bind to DNA.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Human, Mouse, Rat
Reported Reactivity
Other Species
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation
The purified protein was conjugated with FITC under optimal conditions.
Concentration
Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The Annexin V solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this product is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per 100,000 - million cells in a 100 µl volume of Annexin V Binding Buffer (Cat No. 422201). It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Annexin V Staining

  1. Wash cells twice with cold BioLegend Cell Staining Buffer (Cat. No. 420201) and then resuspend cells in Annexin V Binding Buffer (Cat. No. 422201) at a concentration of 1x106 cells/mL.
  2. Transfer 100 µL of cell suspension in 5 mL test tube.
  3. Add 5 µL of fluorochrome conjugated Annexin V.
  4. Stain with a viability dye, such as PI (Cat. No. 421301), 7-AAD (Cat. Nos. 420403 & 420404), or Helix NP dyes (Cat. Nos. 425301, 425303, & 425305), if desired.
  5. Gently vortex the cells and incubate for 15 min at RT (25°C) in the dark.
  6. Add 400* µL of Annexin V Binding Buffer (Cat. No. 422201) to each tube. *For more concentrated samples, add a minimum of 200 µl of Annexin V Binding Buffer in this step.
  7. Analyze by flow cytometry.

For a better experience detecting apoptosis, we now recommend Apotracker™. Cell staining with Apotracker™ is Calcium independent. Thus, no special buffers are required, and the protocol can be shortened for single-step co-staining with other reagents.

Application References
  1. Koopman G, et al. 1994. Blood 84:1415.
  2. Vermes I, et al. 1995. J. Immunol. Methods 184:39.
  3. Dachary-Prigent J, et al. 1993. Blood 81:2554.
  4. Sekine C, et al. 2009. Int Immunol. PubMed
  5. Grujic M, et al. 2010. J. Immunol. 185:1730. PubMed
  6. Mulik RS, et al. 2010. Int J Pharm. 398:190. PubMed
  7. Gupta A, et al. 2011. Leuk Res. 35:1498. PubMed
  8. Speth C,et al. 2013. J Infect Dis. 207:823. PubMed
  9. Wang Q, et al. 2013. Genes Dev. 27:615. PubMed
  10. Gill K, et al. 2013. Biocheim Biophys Acta. 830:2763. PubMed
  11. Juel HB, et al. 2013. PLoS One. 8:64619. PubMed
  12. Hellmann J, et al. 2013. J. Immunol. 191:1383. PubMed
  13. Sequier S, et al. 2013. PLoS One. 8:70937. PubMed
  14. Galski H, et al. 2013. Biochem Pharmacol. 86:584. PubMed
  15. Chen YL, et al. 2013. J Exp Med. PubMed
  16. Lin WH, et al. 2014. PLoS One. 9:83160. PubMed
  17. Salge-Bartles U, 2014. Thromb res. 133:244. PubMed
  18. Zhang X, et al. 2014. Acta Biochim Biophys Sin. 46:261. PubMed
  19. Intermann J, et al. 2014. Cell Signal. 26:1567. PubMed
  20. de Vires M, 2014. Am J Physiol Lung Cell Mol Physiol. 307:240. PubMed
  21. M Parrula MC, et al. 2014. Virus Res. 189:206. PubMed
  22. Passaro C, et al. 2014. Mol Oncol. 9:78. PubMed
  23. Tsou WI, et al. 2014. J Biol Chem. 289:25750. PubMed
  24. Awojoodu AO, et al. 2014. Blood. 124:1941. PubMed
  25. Xiong R, et al. 2014. Toxicol Appl Pharmacol. 280:285. PubMed
  26. Liu J, et al. 2015. J Mol Cell Cardiol. 80:10. PubMed
Product Citations
  1. Yao Z, et al. 2018. J Virol. 92:00:00. PubMed
  2. Uriostegui–Arcos M, et al. 2020. Open Biol. 10:200050. PubMed
  3. Gallego-Murillo JS, et al. 2022. Biotechnol Bioeng. 119:3096. PubMed
  4. Du X, et al. 2023. Nucleic Acids Res. 51:1050. PubMed
  5. Vanoli F, et al. 2023. Oncogenesis. 12:8. PubMed
  6. Lei K, et al. 2023. iScience. 26:106001. PubMed
  7. Ohuchi K, et al. 2023. Biomed Rep. 18:28. PubMed
  8. Do-Thi VA, et al. 2023. Cancer Res Commun. 3:80. PubMed
  9. Perez GI, et al. 2023. Vaccines (Basel). 11:. PubMed
  10. Segaliny AI, et al. 2023. Commun Biol. 6:380. PubMed
  11. Potez M, et al. 2023. Front Oncol. 13:1124272. PubMed
  12. Woodley K, et al. 2023. Nat Commun. 14:2132. PubMed
  13. Quintela M, et al. 2023. Clin Epigenetics. 15:63. PubMed
  14. Quintela M, et al. 2023. Br J Cancer. . PubMed
  15. Zhang T, et al. 2022. EBioMedicine. 77:103872. PubMed
  16. Dhoonmoon A, et al. 2022. Nat Commun. 13:5063. PubMed
  17. Glynn RA, et al. 2022. J Immunol. 208:371. PubMed
  18. Cao H, et al. 2022. Br J Haematol. 198:155. PubMed
  19. Ugamraj HS, et al. 2022. MAbs. 14:2095949. PubMed
  20. Cao L, et al. 2022. Cell Rep. 40:111156. PubMed
  21. Choi UY, et al. 2022. Cell Rep. 40:111234. PubMed
  22. Kimmerling RJ, et al. 2022. Commun Biol. 5:1295. PubMed
  23. Chen X, et al. 2022. Front Pharmacol. 13:1028692. PubMed
  24. Shahid AM, et al. 2022. PLoS One. 17:e0278209. PubMed
  25. Önel T, et al. 2023. Naunyn Schmiedebergs Arch Pharmacol. :. PubMed
  26. Papakonstantinou A, et al. 2022. Int J Mol Sci. 24: . PubMed
  27. Li J, et al. 2023. J Biol Chem. 299:102875. PubMed
  28. Martinelli M, et al. 2023. iScience. 26:105860. PubMed
  29. Tay HG, et al. 2023. Mol Ther. 31:825. PubMed
  30. Dean BD, et al. 2023. J Immunother Cancer. 11: . PubMed
  31. Lieschke E, et al. 2022. Cell Death Differ. 29:1004. PubMed
  32. Zelenka T, et al. 2022. Nat Commun. 13:6954. PubMed
  33. Derudder E, et al. 2016. Proc Natl Acad Sci U S A. 113: 5065-5070. PubMed
  34. Bouhaddou M, et al. 2018. PLoS Comput Biol. 14:e1005985. PubMed
  35. Espinosa-Cueto P, et al. 2017. PLoS One.. 10.1371/journal.pone.0182126. PubMed
  36. Dowling CM, et al. 2021. Sci Adv. 7:. PubMed
  37. Lin YN, et al. 2022. Oncoimmunology. 11:2027136. PubMed
  38. Kim EH, et al. 2020. Elife. 9:00. PubMed
  39. Kitayama J, et al. 2016. PLoS One. 11: 0154542. PubMed
  40. Gedye C, et al. 2016. Sci Rep. 6: 25220. PubMed
  41. Carlsson J, et al. 2015. PLoS One. 10: 0143741. PubMed
  42. Yamauchi T et al. 2018. Cancer cell. 33(3):386-400 . PubMed
  43. Feng W, et al. 2017. Nat Commun. 0.697916667. PubMed
  44. Jones PD, et al. 2018. Arterioscler Thromb Vasc Biol. 38:1711. PubMed
  45. Lopes-Coelho F, et al. 2021. Front Oncol. 11:656229. PubMed
  46. Wang Q, et al. 2022. Nat Commun. 13:3022. PubMed
  47. Olelewe C, et al. 2022. iScience. 25:104340. PubMed
  48. Gupta A, et al. 2011. Leuk Res. 35:1498. PubMed
  49. Fujii T, et al. 2015. Proc Natl Acad Sci U S A. 112: 12800 - 12805. PubMed
  50. Cardoso B, et al. 2015. PLoS One. 10: 0143897. PubMed
  51. Alcon C, et al. 2020. Cell Death Dis. 0.898611111. PubMed
  52. Figueiredo T, et al. 2020. Mol Psychiatry. . PubMed
  53. Bowen ME, et al. 2019. Dev Cell. 50:212. PubMed
  54. Sales–Dias J, et al. 2019. PLoS One. 14:e0217002. PubMed
  55. Santos LC, et al. 2019. Nat Commun. 1.328472222. PubMed
  56. Lim JA, et al. 2018. BMC Cancer. 0.860416667. PubMed
  57. Venter C, et al. 2017. Cell Physiol Biochem. 43:1288. PubMed
  58. Kim Y, et al. 2020. J Neurochem. 155:177. PubMed
  59. Hassan MIA, et al. 2021. Comput Struct Biotechnol J. 19:880. PubMed
  60. Ramalingam P, et al. 2020. J Exp Med. 217:00:00. PubMed
  61. Karavasili C, et al. 2017. International Journal of Pharmaceutics. 10.1016/j.ijpharm.2017.05.061. PubMed
  62. Thompson PJ et al. 2019. Cell metabolism. 29(5):1045-1060 . PubMed
  63. Noguchi F, et al. 2017. Mol Cancer Ther. 1.316666667. PubMed
  64. Kumar S, et al. 2018. Cancers (Basel). 0.724305556. PubMed
  65. Fortin J, et al. 2020. Cancer Cell. 37:308. PubMed
  66. Vereertbrugghen A, et al. 2021. Front Oncol. 11:598319. PubMed
  67. Sun V, et al. 2021. Front Immunol. 12:716661. PubMed
  68. Coray M, et al. 2022. Int J Mol Sci. 23:. PubMed
  69. Soprano M, et al. 2016. PLoS One. 11: 0155970. PubMed
  70. Macpherson L, et al. 2020. Nature. 577:266. PubMed
  71. Chen MS, et al. 2019. Mol Cancer Res. 17:697. PubMed
  72. Ni F, et al. 2019. Cell Stem Cell. 24:608. PubMed
  73. Ning X, et al. 2019. Mol Cell. 74:19. PubMed
  74. Greenblatt SM, et al. 2018. Cancer Cell. 33:1111. PubMed
  75. Naqvi N,et al. 2017. Sci Rep.. 10.1038/s41598-017-12753-1. PubMed
  76. Wang M, et al. 2017. Biochemical and Biophysical Research Communications. 10.1016/j.bbrc.2017.05.097. PubMed
  77. Beeravolu N, McKee C, Chaudhry G 2017. J App Toxicol. 10.1002/jat.3469. PubMed
  78. Kim OV, et al. 2022. iScience. 25:104654. PubMed
  79. Shahzadi SK, et al. 2022. Clin Sci (Lond). 136:181. PubMed
  80. Kolbrink B, et al. 2022. Biochem J. 479:259. PubMed
  81. He C, et al. 2021. Oncoimmunology. 1897295:10. PubMed
  82. Pfalzgraff A, et al. 2016. Sci Rep. 6:31577. PubMed
  83. O'Neill K, et al. 2016. Genes Dev. 30: 973-988. PubMed
  84. Liu J, et al. 2015. J Mol Cell Cardiol. 80:10. PubMed
  85. Vries M, et al. 2014. Am J Physiol Lung Cell Mol Physiol. 307:240. PubMed
  86. Esteghamat F, et al. 2019. Nat Genet. 51:1233. PubMed
  87. Blümel E, et al. 2020. Oncoimmunology. 9:1751561. PubMed
  88. Sekine C, et al. 2009. Int Immunol. 1.079861111. PubMed
  89. Kinsella S, et al. 2021. Cell Rep. 37:109789. PubMed
  90. O'Connor MJ, et al. 2021. Oncogene. 40:4872. PubMed
  91. Parrula M, et al. 2014. Virus Res. 189:206. PubMed
  92. Brigger D, et al. 2015. Cell Death Dis. 6: e1861. PubMed
  93. Zhang J, et al. 2016. Cell Death Dis. 7:e2266. PubMed
  94. Wang D, et al. 2016. J Cell Sci. 129: 2261 - 2272. PubMed
  95. Uchtenhagen H, et al. 2016. Nat Commun. 7:12614. PubMed
  96. Geiger R, et al. 2016. Cell. 167:829-842. PubMed
  97. Rauzan M, et al. 2017. PLoS One. 12:e0174107. PubMed
  98. Liu Y, et al. 2017. Acta Biomater. 10.1016/j.actbio.2017.08.021. PubMed
  99. Chiani M, et al. 2017. Artif Cells Nanomed Biotechnol. 10.1080/21691401.2017.1337029. PubMed
  100. Yang L, et al. 2021. Cell Death Differ. 28:2616. PubMed
  101. Martín Monreal MT, et al. 2021. Front Immunol. 12:716250. PubMed
  102. Schmitz RL, et al. 2021. Cells. 10:. PubMed
  103. Babaei A, et al. 2021. Adv Pharm Bull. 11:361. PubMed
  104. Madala HR, et al. 2020. Cancer Res. 3492:80. PubMed
  105. Clements KE, et al. 2020. Nat Commun. 4.706944444. PubMed
  106. Kamiyama N, et al. 2017. Antiviral Res. 10.1016/j.antiviral.2017.08.007. PubMed
  107. Montero–Herradón S, et al. 2017. Organogenesis. 0.675. PubMed
  108. Nunes SC, et al. 2018. Sci Rep. 6.939583333. PubMed
  109. Sharif T, et al. 2018. Autophagy. 1.101388889. PubMed
  110. Eichelmann AK, et al. 2018. Sci Rep. 8:17553. PubMed
  111. Blümel E, et al. 2019. Oncoimmunology. 8:e1641387. PubMed
  112. Morimoto A, et al. 2021. Nat Commun. 12:2136. PubMed
  113. Norkin M, et al. 2021. Cell Rep. 35:109026. PubMed
  114. Krauss PL, et al. 2021. Front Immunol. 12:730672. PubMed
  115. Zhu Y, et al. 2022. Clin Transl Med. 12:e887. PubMed
  116. Khatib JB, et al. 2022. Oncotarget. 13:1078. PubMed
  117. Salge-Bartels U, et al. 2014. Thromb Res. 133:244. PubMed
  118. Passaro C, et al. 2014. Mol Oncol. 9:78. PubMed
  119. Ligtenberg M, et al. 2016. J Immunol. 196: 759 - 766. PubMed
  120. Hrdinka M, et al. 2016. PLoS One. 11: 0162863. PubMed
  121. Herold N, et al. 2017. Nat Med. 23:256-263. PubMed
  122. Xie S, et al. 2021. Sci Rep. 0.660416667. PubMed
  123. Müller I, et al. 2020. Mol Cell. 970:77. PubMed
  124. Liu H, et al. 2020. Cell Death Dis. 0.767361111. PubMed
  125. Zervou S, et al. 2017. PLoS One.. 10.1371/journal.pone.0182994. PubMed
  126. Ishidome T et al. 2017. EBioMedicine. 22:89-99 . PubMed
  127. Matsuda K, et al. 2021. Cell Rep Methods. 1:100122. PubMed
  128. Vanoli F, et al. 2021. Oncogene. 40:5095. PubMed
  129. Liu H, et al. 2021. J Immunother Cancer. 9:. PubMed
  130. Smith CM, et al. 2021. Biochem J. 478:3331. PubMed
  131. Li Y, et al. 2021. Sci Transl Med. 13:. PubMed
  132. Meyer N, et al. 2021. J Clin Med. 10:. PubMed
  133. Yoon Y, et al. 2016. Stem Cell Reports. 7:840-853. PubMed
  134. Chheda Z, et al. 2016. J Immunol. 197: 2016 - 2026. PubMed
  135. Slone E, et al. 2015. J Leukoc Biol. 98: 791 - 804. PubMed
  136. Séguier S, et al. 2013. PLoS One. 8:70937. PubMed
  137. Litzenburger UM, et al. 2017. Genome Biol. 18:15. PubMed
  138. Rajavel T, et al. 2017. Sci Rep. 2.665277778. PubMed
  139. Grujic M, et al. 2010. J Immunol. 185:1730. PubMed
  140. Gholamrezaei M, et al. 2021. Iran J Parasitol. 15:475. PubMed
  141. Meyer N, et al. 2021. Int J Mol Sci. 22:. PubMed
  142. Kolbrink B, et al. 2022. Cell Mol Life Sci. 79:387. PubMed
  143. Wang Q, et al. 2013. Genes Dev. 27:615. PubMed
  144. Douguet L, et al. 2016. PLoS One. 11:e0166164. PubMed
  145. Toutounchian J, et al. 2016. Mol Pharmacol. 91(1):1-13. PubMed
  146. Pajarillo E, et al. 2020. J Biol Chem. 295:3040. PubMed
  147. Matsumoto A, et al. 2019. J Extracell Vesicles. 9:1696517. PubMed
  148. Pirali T, et al. 2017. ChemMedChem. 1.570833333. PubMed
  149. Ishida M, et al. 2021. Int J Mol Sci. 22:. PubMed
  150. Lee DH, et al. 2020. Circ Res. 127:1182. PubMed
  151. Alsina-Sanchis E, et al. 2020. Mol Cancer Res. . PubMed
  152. L Chang, Y Li, D Kaplan 2016. Sci Rep. 6:36862. PubMed
  153. Becker A, et al. 2016. Sci Rep. 6: 33847. PubMed
  154. Kumai T, et al. 2015. Sci Rep. 5:16280. PubMed
  155. Polak R, et al. 2015. Blood. 126: 2404 - 2414. PubMed
  156. Hafez A, et al. 2017. Oncogenesis. 10.1038/oncsis.2017.46. PubMed
  157. Putheti P, et al. 2010. PLoS One. 5:e8706. PubMed
  158. Nastasi C, et al. 2021. Sci Rep. 11:1458. PubMed
  159. Molinar-Inglis O, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  160. Erdogan M, et al. 2022. Chem Biodivers. 19:e202200659. PubMed
  161. Galski H, et al. 2013. Biochem Pharmacol. 86:584. PubMed
  162. Tsou W, et al. 2014. J Biol Chem. 289:25750. PubMed
  163. Dhoonmoon A, et al. 2020. Nucleic Acids Res. 48:7252. PubMed
  164. Gladow N, et al. 2020. PLoS One. 15:e0227734. PubMed
  165. Lee HW, et al. 2018. Am J Physiol Renal Physiol. 314:F280. PubMed
  166. Ki H, et al. 2017. Biomed Pharmacother. 10.1016/j.biopha.2017.09.118. PubMed
  167. Shadboorestan A, et al. 2022. Iran J Basic Med Sci. 25:506. PubMed
  168. Huang Y, et al. 2022. Front Cell Dev Biol. 9:837777. PubMed
  169. Babaei A, et al. 2020. Daru. 28:555. PubMed
  170. King R, et al. 2021. Sci Adv. 7:eabj5293. PubMed
  171. Cai Z, et al. 2020. Cell Rep. 31:107816. PubMed
  172. Liu B, et al. 2016. J Biol Chem. 291: 23869 - 23881. PubMed
  173. Lhuillier C, et al. 2015. J Biol Chem. 290: 16797 - 16811. PubMed
  174. Passaro C, et al. 2013. Endocr Relat Cancer. 20:633. PubMed
  175. Mulik R, et al. 2010. Int J Pharm. 398:190. PubMed
  176. Speth C, et al. 2013. J Infect Dis. 207:823. PubMed
  177. Schuler F, et al. 2017. Nat Commun. . 10.1038/s41467-017-01850-4. PubMed
  178. Di Somma S, et al. 2019. Cancers (Basel). 1.70625. PubMed
  179. Abu El Maaty MA, et al. 2021. Sci Adv. 7: . PubMed
  180. Bahl S, et al. 2021. Cell Death Dis. 12:469. PubMed
  181. Jackson LM, et al. 2021. Nucleic Acids Res. 49:12855. PubMed
  182. Lin W, et al. 2014. PLoS One. 9:83160. PubMed
  183. Zhang X, et al. 2014. Acta Biochim Biophys Sin. 46:261. PubMed
  184. CO L, et al. 2015. Nat Commun. 6: 7739. PubMed
  185. Huang YL, et al. 2020. Elife. 9:00. PubMed
  186. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  187. Fang P, et al. 2019. Commun Biol. 0.315972222. PubMed
  188. Kumar S, et al. 2019. Int J Cancer. 146:1652. PubMed
  189. Zhao CC, et al. 2018. Oncol Rep. 40:3392. PubMed
  190. Schleicher EM, et al. 2018. Nucleic Acids Res. 46:8908. PubMed
  191. Thomas A, et al. 2017. PLoS One.. 10.1371/journal.pone.0183542. PubMed
  192. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  193. Alcon C, et al. 2021. Cells. 10:. PubMed
  194. Cao H, et al. 2021. Nat Commun. 12:1792. PubMed
  195. Faria M, et al. 2017. PLoS One. 12(2):e0172689. PubMed
  196. Jones P, et al. 2016. J Biol Chem. 291: 16318 - 16327. PubMed
  197. Awojoodu A, et al. 2014. Blood. 124:1941. PubMed
  198. Intemann J, et al. 2014. Cell Signal. 26:1567. PubMed
  199. Clements KE, et al. 2018. Nucleic Acids Res. 46:8898. PubMed
  200. Bostanabad SY, et al. 2021. Sci Rep. 11:1539. PubMed
  201. Monzen S, et al. 2022. Mol Clin Oncol. 16:19. PubMed
  202. Konda P, et al. 2022. Am J Cancer Res. 12:210. PubMed
  203. Wu J, et al. 2021. Adv Sci (Weinh). 8:e2101029. PubMed
  204. Mendès C, et al. 2019. Sci Rep. 9:14107. PubMed
  205. Lopes–Coelho F, et al. 2017. Oncotarget. 8:82803. PubMed
  206. Lu Y, et al. 2018. Cancer Cell. 33:1048. PubMed
  207. Thanuthanakhun N, et al. 2017. PLoS One. . 10.1371/journal.pone.0187610. PubMed
  208. Kuntz E, et al. 2017. Nat Med. 10.1038/nm.4399. PubMed
  209. Tu Z, et al. 2022. Cell Rep. 40:111072. PubMed
  210. Bensberg M, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  211. Paparella AS, et al. 2021. Nat Commun. 12:6285. PubMed
  212. Huang YL, et al. 2021. iScience. 24:103168. PubMed
  213. Zhang Y, et al. 2021. Cell Death Dis. 0.563194444. PubMed
  214. Kang JH, et al. 2020. Cell Death Dis. 0.803472222. PubMed
  215. Dewdney B, et al. 2020. Sci Rep. 10:16769. PubMed
  216. Simoni L, et al. 2020. Cell Rep. 33:108330. PubMed
  217. Coutaz M, et al. 2016. Sci Rep. 6:39117. PubMed
  218. Akane K, et al. 2016. Proc Natl Acad Sci U S A. 113: 2460 - 2465. PubMed
  219. Xiong R, et al. 2014. Toxicol Appl Pharmacol. 280:285. PubMed
  220. Chen Y, et al. 2013. J Exp Med. 210:2515. PubMed
  221. Siddhartha V, et al. 2017. Artif Cells Nanomed Biotechnol . 10.1080/21691401.2017.1313267. PubMed
  222. He J, et al. 2017. FASEB J. 31:2893. PubMed
  223. Lyu X, et al. 2019. BMC Genomics. 1.235416667. PubMed
  224. Jing Y, et al. 2019. J Allergy Clin Immunol. 144:1377. PubMed
  225. Quan M, et al. 2019. Oncol Rep. 41:3051. PubMed
  226. Kasikara C, et al. 2021. J Clin Invest. 131:. PubMed
  227. Ning N, et al. 2022. Theranostics. 12:5537. PubMed
  228. Bottardi S, et al. 2020. Exp Hematol. 68:88. PubMed
  229. Young MM, et al. 2019. Cell Death Dis. 1.004861111. PubMed
  230. Santos I, et al. 2019. Nutrients. 2.210416667. PubMed
  231. Vancsik T, et al. 2019. Cancer Med. 3.313888889. PubMed
  232. Zheng M, et al. 2019. Proc Natl Acad Sci U S A. 116:12422. PubMed
  233. Zheng Q, et al. 2017. Mol Oncol. 10.1002/1878-0261.12056. PubMed
  234. Wang Y, et al. 2022. Front Cardiovasc Med. 9:876087. PubMed
  235. Shankman LS, et al. 2021. Curr Biol. 31:2469. PubMed
  236. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
  237. Pahari S, et al. 2020. Autophagy. 1.375694444. PubMed
  238. Schleicher EM, et al. 2020. PLoS Genet. 16:e1009176. PubMed
  239. Langsch S, et al. 2016. Cancer Res . 76: 4160 - 4169. PubMed
  240. Xiong R, et al. 2015. Mol Pharmacol. 88: 1045 - 1054. PubMed
  241. Hellmann J, et al. 2013. J Immunol. 191:1383. PubMed
  242. Juel H, et al. 2013. PLoS One. 8:64619. PubMed
  243. Gill K, et al. 2013. Biochim Biophys Acta. 1830:2763. PubMed
  244. Yao Z, et al. 2018. J Virol. 92:00:00. PubMed
  245. Uriostegui–Arcos M, et al. 2020. Open Biol. 10:200050. PubMed
  246. Gallego-Murillo JS, et al. 2022. Biotechnol Bioeng. 119:3096. PubMed
  247. Du X, et al. 2023. Nucleic Acids Res. 51:1050. PubMed
  248. Vanoli F, et al. 2023. Oncogenesis. 12:8. PubMed
  249. Lei K, et al. 2023. iScience. 26:106001. PubMed
  250. Ohuchi K, et al. 2023. Biomed Rep. 18:28. PubMed
  251. Do-Thi VA, et al. 2023. Cancer Res Commun. 3:80. PubMed
  252. Perez GI, et al. 2023. Vaccines (Basel). 11:. PubMed
  253. Segaliny AI, et al. 2023. Commun Biol. 6:380. PubMed
  254. Potez M, et al. 2023. Front Oncol. 13:1124272. PubMed
  255. Woodley K, et al. 2023. Nat Commun. 14:2132. PubMed
  256. Quintela M, et al. 2023. Clin Epigenetics. 15:63. PubMed
  257. Quintela M, et al. 2023. Br J Cancer. . PubMed
  258. Zhang T, et al. 2022. EBioMedicine. 77:103872. PubMed
  259. Dhoonmoon A, et al. 2022. Nat Commun. 13:5063. PubMed
  260. Glynn RA, et al. 2022. J Immunol. 208:371. PubMed
  261. Cao H, et al. 2022. Br J Haematol. 198:155. PubMed
  262. Ugamraj HS, et al. 2022. MAbs. 14:2095949. PubMed
  263. Cao L, et al. 2022. Cell Rep. 40:111156. PubMed
  264. Choi UY, et al. 2022. Cell Rep. 40:111234. PubMed
  265. Kimmerling RJ, et al. 2022. Commun Biol. 5:1295. PubMed
  266. Chen X, et al. 2022. Front Pharmacol. 13:1028692. PubMed
  267. Shahid AM, et al. 2022. PLoS One. 17:e0278209. PubMed
  268. Önel T, et al. 2023. Naunyn Schmiedebergs Arch Pharmacol. :. PubMed
  269. Papakonstantinou A, et al. 2022. Int J Mol Sci. 24: . PubMed
  270. Li J, et al. 2023. J Biol Chem. 299:102875. PubMed
  271. Martinelli M, et al. 2023. iScience. 26:105860. PubMed
  272. Tay HG, et al. 2023. Mol Ther. 31:825. PubMed
  273. Dean BD, et al. 2023. J Immunother Cancer. 11: . PubMed
  274. Lieschke E, et al. 2022. Cell Death Differ. 29:1004. PubMed
  275. Zelenka T, et al. 2022. Nat Commun. 13:6954. PubMed
  276. Derudder E, et al. 2016. Proc Natl Acad Sci U S A. 113: 5065-5070. PubMed
  277. Bouhaddou M, et al. 2018. PLoS Comput Biol. 14:e1005985. PubMed
  278. Espinosa-Cueto P, et al. 2017. PLoS One.. 10.1371/journal.pone.0182126. PubMed
  279. Dowling CM, et al. 2021. Sci Adv. 7:. PubMed
  280. Lin YN, et al. 2022. Oncoimmunology. 11:2027136. PubMed
  281. Kim EH, et al. 2020. Elife. 9:00. PubMed
  282. Kitayama J, et al. 2016. PLoS One. 11: 0154542. PubMed
  283. Gedye C, et al. 2016. Sci Rep. 6: 25220. PubMed
  284. Carlsson J, et al. 2015. PLoS One. 10: 0143741. PubMed
  285. Yamauchi T et al. 2018. Cancer cell. 33(3):386-400 . PubMed
  286. Feng W, et al. 2017. Nat Commun. 0.697916667. PubMed
  287. Jones PD, et al. 2018. Arterioscler Thromb Vasc Biol. 38:1711. PubMed
  288. Lopes-Coelho F, et al. 2021. Front Oncol. 11:656229. PubMed
  289. Wang Q, et al. 2022. Nat Commun. 13:3022. PubMed
  290. Olelewe C, et al. 2022. iScience. 25:104340. PubMed
  291. Gupta A, et al. 2011. Leuk Res. 35:1498. PubMed
  292. Fujii T, et al. 2015. Proc Natl Acad Sci U S A. 112: 12800 - 12805. PubMed
  293. Cardoso B, et al. 2015. PLoS One. 10: 0143897. PubMed
  294. Alcon C, et al. 2020. Cell Death Dis. 0.898611111. PubMed
  295. Figueiredo T, et al. 2020. Mol Psychiatry. . PubMed
  296. Bowen ME, et al. 2019. Dev Cell. 50:212. PubMed
  297. Sales–Dias J, et al. 2019. PLoS One. 14:e0217002. PubMed
  298. Santos LC, et al. 2019. Nat Commun. 1.328472222. PubMed
  299. Lim JA, et al. 2018. BMC Cancer. 0.860416667. PubMed
  300. Venter C, et al. 2017. Cell Physiol Biochem. 43:1288. PubMed
  301. Kim Y, et al. 2020. J Neurochem. 155:177. PubMed
  302. Hassan MIA, et al. 2021. Comput Struct Biotechnol J. 19:880. PubMed
  303. Ramalingam P, et al. 2020. J Exp Med. 217:00:00. PubMed
  304. Karavasili C, et al. 2017. International Journal of Pharmaceutics. 10.1016/j.ijpharm.2017.05.061. PubMed
  305. Thompson PJ et al. 2019. Cell metabolism. 29(5):1045-1060 . PubMed
  306. Noguchi F, et al. 2017. Mol Cancer Ther. 1.316666667. PubMed
  307. Kumar S, et al. 2018. Cancers (Basel). 0.724305556. PubMed
  308. Fortin J, et al. 2020. Cancer Cell. 37:308. PubMed
  309. Vereertbrugghen A, et al. 2021. Front Oncol. 11:598319. PubMed
  310. Sun V, et al. 2021. Front Immunol. 12:716661. PubMed
  311. Coray M, et al. 2022. Int J Mol Sci. 23:. PubMed
  312. Soprano M, et al. 2016. PLoS One. 11: 0155970. PubMed
  313. Macpherson L, et al. 2020. Nature. 577:266. PubMed
  314. Chen MS, et al. 2019. Mol Cancer Res. 17:697. PubMed
  315. Ni F, et al. 2019. Cell Stem Cell. 24:608. PubMed
  316. Ning X, et al. 2019. Mol Cell. 74:19. PubMed
  317. Greenblatt SM, et al. 2018. Cancer Cell. 33:1111. PubMed
  318. Naqvi N,et al. 2017. Sci Rep.. 10.1038/s41598-017-12753-1. PubMed
  319. Wang M, et al. 2017. Biochemical and Biophysical Research Communications. 10.1016/j.bbrc.2017.05.097. PubMed
  320. Beeravolu N, McKee C, Chaudhry G 2017. J App Toxicol. 10.1002/jat.3469. PubMed
  321. Kim OV, et al. 2022. iScience. 25:104654. PubMed
  322. Shahzadi SK, et al. 2022. Clin Sci (Lond). 136:181. PubMed
  323. Kolbrink B, et al. 2022. Biochem J. 479:259. PubMed
  324. He C, et al. 2021. Oncoimmunology. 1897295:10. PubMed
  325. Pfalzgraff A, et al. 2016. Sci Rep. 6:31577. PubMed
  326. O'Neill K, et al. 2016. Genes Dev. 30: 973-988. PubMed
  327. Liu J, et al. 2015. J Mol Cell Cardiol. 80:10. PubMed
  328. Vries M, et al. 2014. Am J Physiol Lung Cell Mol Physiol. 307:240. PubMed
  329. Esteghamat F, et al. 2019. Nat Genet. 51:1233. PubMed
  330. Blümel E, et al. 2020. Oncoimmunology. 9:1751561. PubMed
  331. Sekine C, et al. 2009. Int Immunol. 1.079861111. PubMed
  332. Kinsella S, et al. 2021. Cell Rep. 37:109789. PubMed
  333. O'Connor MJ, et al. 2021. Oncogene. 40:4872. PubMed
  334. Parrula M, et al. 2014. Virus Res. 189:206. PubMed
  335. Brigger D, et al. 2015. Cell Death Dis. 6: e1861. PubMed
  336. Zhang J, et al. 2016. Cell Death Dis. 7:e2266. PubMed
  337. Wang D, et al. 2016. J Cell Sci. 129: 2261 - 2272. PubMed
  338. Uchtenhagen H, et al. 2016. Nat Commun. 7:12614. PubMed
  339. Geiger R, et al. 2016. Cell. 167:829-842. PubMed
  340. Rauzan M, et al. 2017. PLoS One. 12:e0174107. PubMed
  341. Liu Y, et al. 2017. Acta Biomater. 10.1016/j.actbio.2017.08.021. PubMed
  342. Chiani M, et al. 2017. Artif Cells Nanomed Biotechnol. 10.1080/21691401.2017.1337029. PubMed
  343. Yang L, et al. 2021. Cell Death Differ. 28:2616. PubMed
  344. Martín Monreal MT, et al. 2021. Front Immunol. 12:716250. PubMed
  345. Schmitz RL, et al. 2021. Cells. 10:. PubMed
  346. Babaei A, et al. 2021. Adv Pharm Bull. 11:361. PubMed
  347. Madala HR, et al. 2020. Cancer Res. 3492:80. PubMed
  348. Clements KE, et al. 2020. Nat Commun. 4.706944444. PubMed
  349. Kamiyama N, et al. 2017. Antiviral Res. 10.1016/j.antiviral.2017.08.007. PubMed
  350. Montero–Herradón S, et al. 2017. Organogenesis. 0.675. PubMed
  351. Nunes SC, et al. 2018. Sci Rep. 6.939583333. PubMed
  352. Sharif T, et al. 2018. Autophagy. 1.101388889. PubMed
  353. Eichelmann AK, et al. 2018. Sci Rep. 8:17553. PubMed
  354. Blümel E, et al. 2019. Oncoimmunology. 8:e1641387. PubMed
  355. Morimoto A, et al. 2021. Nat Commun. 12:2136. PubMed
  356. Norkin M, et al. 2021. Cell Rep. 35:109026. PubMed
  357. Krauss PL, et al. 2021. Front Immunol. 12:730672. PubMed
  358. Zhu Y, et al. 2022. Clin Transl Med. 12:e887. PubMed
  359. Khatib JB, et al. 2022. Oncotarget. 13:1078. PubMed
  360. Salge-Bartels U, et al. 2014. Thromb Res. 133:244. PubMed
  361. Passaro C, et al. 2014. Mol Oncol. 9:78. PubMed
  362. Ligtenberg M, et al. 2016. J Immunol. 196: 759 - 766. PubMed
  363. Hrdinka M, et al. 2016. PLoS One. 11: 0162863. PubMed
  364. Herold N, et al. 2017. Nat Med. 23:256-263. PubMed
  365. Xie S, et al. 2021. Sci Rep. 0.660416667. PubMed
  366. Müller I, et al. 2020. Mol Cell. 970:77. PubMed
  367. Liu H, et al. 2020. Cell Death Dis. 0.767361111. PubMed
  368. Zervou S, et al. 2017. PLoS One.. 10.1371/journal.pone.0182994. PubMed
  369. Ishidome T et al. 2017. EBioMedicine. 22:89-99 . PubMed
  370. Matsuda K, et al. 2021. Cell Rep Methods. 1:100122. PubMed
  371. Vanoli F, et al. 2021. Oncogene. 40:5095. PubMed
  372. Liu H, et al. 2021. J Immunother Cancer. 9:. PubMed
  373. Smith CM, et al. 2021. Biochem J. 478:3331. PubMed
  374. Li Y, et al. 2021. Sci Transl Med. 13:. PubMed
  375. Meyer N, et al. 2021. J Clin Med. 10:. PubMed
  376. Yoon Y, et al. 2016. Stem Cell Reports. 7:840-853. PubMed
  377. Chheda Z, et al. 2016. J Immunol. 197: 2016 - 2026. PubMed
  378. Slone E, et al. 2015. J Leukoc Biol. 98: 791 - 804. PubMed
  379. Séguier S, et al. 2013. PLoS One. 8:70937. PubMed
  380. Litzenburger UM, et al. 2017. Genome Biol. 18:15. PubMed
  381. Rajavel T, et al. 2017. Sci Rep. 2.665277778. PubMed
  382. Grujic M, et al. 2010. J Immunol. 185:1730. PubMed
  383. Gholamrezaei M, et al. 2021. Iran J Parasitol. 15:475. PubMed
  384. Meyer N, et al. 2021. Int J Mol Sci. 22:. PubMed
  385. Kolbrink B, et al. 2022. Cell Mol Life Sci. 79:387. PubMed
  386. Wang Q, et al. 2013. Genes Dev. 27:615. PubMed
  387. Douguet L, et al. 2016. PLoS One. 11:e0166164. PubMed
  388. Toutounchian J, et al. 2016. Mol Pharmacol. 91(1):1-13. PubMed
  389. Pajarillo E, et al. 2020. J Biol Chem. 295:3040. PubMed
  390. Matsumoto A, et al. 2019. J Extracell Vesicles. 9:1696517. PubMed
  391. Pirali T, et al. 2017. ChemMedChem. 1.570833333. PubMed
  392. Ishida M, et al. 2021. Int J Mol Sci. 22:. PubMed
  393. Lee DH, et al. 2020. Circ Res. 127:1182. PubMed
  394. Alsina-Sanchis E, et al. 2020. Mol Cancer Res. . PubMed
  395. L Chang, Y Li, D Kaplan 2016. Sci Rep. 6:36862. PubMed
  396. Becker A, et al. 2016. Sci Rep. 6: 33847. PubMed
  397. Kumai T, et al. 2015. Sci Rep. 5:16280. PubMed
  398. Polak R, et al. 2015. Blood. 126: 2404 - 2414. PubMed
  399. Hafez A, et al. 2017. Oncogenesis. 10.1038/oncsis.2017.46. PubMed
  400. Putheti P, et al. 2010. PLoS One. 5:e8706. PubMed
  401. Nastasi C, et al. 2021. Sci Rep. 11:1458. PubMed
  402. Molinar-Inglis O, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  403. Erdogan M, et al. 2022. Chem Biodivers. 19:e202200659. PubMed
  404. Galski H, et al. 2013. Biochem Pharmacol. 86:584. PubMed
  405. Tsou W, et al. 2014. J Biol Chem. 289:25750. PubMed
  406. Dhoonmoon A, et al. 2020. Nucleic Acids Res. 48:7252. PubMed
  407. Gladow N, et al. 2020. PLoS One. 15:e0227734. PubMed
  408. Lee HW, et al. 2018. Am J Physiol Renal Physiol. 314:F280. PubMed
  409. Ki H, et al. 2017. Biomed Pharmacother. 10.1016/j.biopha.2017.09.118. PubMed
  410. Shadboorestan A, et al. 2022. Iran J Basic Med Sci. 25:506. PubMed
  411. Huang Y, et al. 2022. Front Cell Dev Biol. 9:837777. PubMed
  412. Babaei A, et al. 2020. Daru. 28:555. PubMed
  413. King R, et al. 2021. Sci Adv. 7:eabj5293. PubMed
  414. Cai Z, et al. 2020. Cell Rep. 31:107816. PubMed
  415. Liu B, et al. 2016. J Biol Chem. 291: 23869 - 23881. PubMed
  416. Lhuillier C, et al. 2015. J Biol Chem. 290: 16797 - 16811. PubMed
  417. Passaro C, et al. 2013. Endocr Relat Cancer. 20:633. PubMed
  418. Mulik R, et al. 2010. Int J Pharm. 398:190. PubMed
  419. Speth C, et al. 2013. J Infect Dis. 207:823. PubMed
  420. Schuler F, et al. 2017. Nat Commun. . 10.1038/s41467-017-01850-4. PubMed
  421. Di Somma S, et al. 2019. Cancers (Basel). 1.70625. PubMed
  422. Abu El Maaty MA, et al. 2021. Sci Adv. 7: . PubMed
  423. Bahl S, et al. 2021. Cell Death Dis. 12:469. PubMed
  424. Jackson LM, et al. 2021. Nucleic Acids Res. 49:12855. PubMed
  425. Lin W, et al. 2014. PLoS One. 9:83160. PubMed
  426. Zhang X, et al. 2014. Acta Biochim Biophys Sin. 46:261. PubMed
  427. CO L, et al. 2015. Nat Commun. 6: 7739. PubMed
  428. Huang YL, et al. 2020. Elife. 9:00. PubMed
  429. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  430. Fang P, et al. 2019. Commun Biol. 0.315972222. PubMed
  431. Kumar S, et al. 2019. Int J Cancer. 146:1652. PubMed
  432. Zhao CC, et al. 2018. Oncol Rep. 40:3392. PubMed
  433. Schleicher EM, et al. 2018. Nucleic Acids Res. 46:8908. PubMed
  434. Thomas A, et al. 2017. PLoS One.. 10.1371/journal.pone.0183542. PubMed
  435. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  436. Alcon C, et al. 2021. Cells. 10:. PubMed
  437. Cao H, et al. 2021. Nat Commun. 12:1792. PubMed
  438. Faria M, et al. 2017. PLoS One. 12(2):e0172689. PubMed
  439. Jones P, et al. 2016. J Biol Chem. 291: 16318 - 16327. PubMed
  440. Awojoodu A, et al. 2014. Blood. 124:1941. PubMed
  441. Intemann J, et al. 2014. Cell Signal. 26:1567. PubMed
  442. Clements KE, et al. 2018. Nucleic Acids Res. 46:8898. PubMed
  443. Bostanabad SY, et al. 2021. Sci Rep. 11:1539. PubMed
  444. Monzen S, et al. 2022. Mol Clin Oncol. 16:19. PubMed
  445. Konda P, et al. 2022. Am J Cancer Res. 12:210. PubMed
  446. Wu J, et al. 2021. Adv Sci (Weinh). 8:e2101029. PubMed
  447. Mendès C, et al. 2019. Sci Rep. 9:14107. PubMed
  448. Lopes–Coelho F, et al. 2017. Oncotarget. 8:82803. PubMed
  449. Lu Y, et al. 2018. Cancer Cell. 33:1048. PubMed
  450. Thanuthanakhun N, et al. 2017. PLoS One. . 10.1371/journal.pone.0187610. PubMed
  451. Kuntz E, et al. 2017. Nat Med. 10.1038/nm.4399. PubMed
  452. Tu Z, et al. 2022. Cell Rep. 40:111072. PubMed
  453. Bensberg M, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  454. Paparella AS, et al. 2021. Nat Commun. 12:6285. PubMed
  455. Huang YL, et al. 2021. iScience. 24:103168. PubMed
  456. Zhang Y, et al. 2021. Cell Death Dis. 0.563194444. PubMed
  457. Kang JH, et al. 2020. Cell Death Dis. 0.803472222. PubMed
  458. Dewdney B, et al. 2020. Sci Rep. 10:16769. PubMed
  459. Simoni L, et al. 2020. Cell Rep. 33:108330. PubMed
  460. Coutaz M, et al. 2016. Sci Rep. 6:39117. PubMed
  461. Akane K, et al. 2016. Proc Natl Acad Sci U S A. 113: 2460 - 2465. PubMed
  462. Xiong R, et al. 2014. Toxicol Appl Pharmacol. 280:285. PubMed
  463. Chen Y, et al. 2013. J Exp Med. 210:2515. PubMed
  464. Siddhartha V, et al. 2017. Artif Cells Nanomed Biotechnol . 10.1080/21691401.2017.1313267. PubMed
  465. He J, et al. 2017. FASEB J. 31:2893. PubMed
  466. Lyu X, et al. 2019. BMC Genomics. 1.235416667. PubMed
  467. Jing Y, et al. 2019. J Allergy Clin Immunol. 144:1377. PubMed
  468. Quan M, et al. 2019. Oncol Rep. 41:3051. PubMed
  469. Kasikara C, et al. 2021. J Clin Invest. 131:. PubMed
  470. Ning N, et al. 2022. Theranostics. 12:5537. PubMed
  471. Bottardi S, et al. 2020. Exp Hematol. 68:88. PubMed
  472. Young MM, et al. 2019. Cell Death Dis. 1.004861111. PubMed
  473. Santos I, et al. 2019. Nutrients. 2.210416667. PubMed
  474. Vancsik T, et al. 2019. Cancer Med. 3.313888889. PubMed
  475. Zheng M, et al. 2019. Proc Natl Acad Sci U S A. 116:12422. PubMed
  476. Zheng Q, et al. 2017. Mol Oncol. 10.1002/1878-0261.12056. PubMed
  477. Wang Y, et al. 2022. Front Cardiovasc Med. 9:876087. PubMed
  478. Shankman LS, et al. 2021. Curr Biol. 31:2469. PubMed
  479. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
  480. Pahari S, et al. 2020. Autophagy. 1.375694444. PubMed
  481. Schleicher EM, et al. 2020. PLoS Genet. 16:e1009176. PubMed
  482. Langsch S, et al. 2016. Cancer Res . 76: 4160 - 4169. PubMed
  483. Xiong R, et al. 2015. Mol Pharmacol. 88: 1045 - 1054. PubMed
  484. Hellmann J, et al. 2013. J Immunol. 191:1383. PubMed
  485. Juel H, et al. 2013. PLoS One. 8:64619. PubMed
  486. Gill K, et al. 2013. Biochim Biophys Acta. 1830:2763. PubMed
RRID
AB_2629519 (BioLegend Cat. No. 640945)
AB_2561292 (BioLegend Cat. No. 640906)
AB_2561291 (BioLegend Cat. No. 640905)

Antigen Details

Biology Area
Apoptosis/Tumor Suppressors/Cell Death, Cell Biology, Neuroscience
Gene ID
308 View all products for this Gene ID
UniProt
View information about Annexin V on UniProt.org

Related FAQs

How is your Annexin made and what sequence does it cover?

It is made in E. coli, covering human aa Met1-Asp320.

How does pH and staining temperature affect Annexin V-Phosphatidylserine binding?

Annexin-Phosphatidylserine binding is lost below pH 5.2 and with prolonged incubation over a temperature of 42°C.

Why do I need to use Annexin V Binding Buffer?

Annexin V binding requires the presence of calcium in the solution.  So, we provide Annexin V Binding Buffer (cat # 422201), which is optimized for the best performance of Annexin V staining.

Can I use RPMI during Annexin V staining?

It is best to follow protocol as described on the product data sheet. Moreover, RPMI 1640 has a relatively high concentration of phosphate and low calcium ion concentration, which negatively impacts Annexin binding to its target phosphatidylserine (PS). Measurement of cell death by using Annexin V may also be significantly affected by time of incubation on ice, calcium concentration, and type of medium.

Can I freeze Annexin V conjugates?

It should not be frozen as it will lead to loss of biological activity due to dimerization.

Is Annexin V suitable for conjugation with the Maxpar® kit for CyTOF®?

Maxpar® Labeling kits require the protein to be partially reduced, so the metal chelate can be introduced through an SH group in the hinge region of the reduced antibody. Human Annexin V contains only one Cysteine which was reported to be chemically inactive. Thus, the Maxpar® labeling protocol would not work with Annexin V, unless a free –SH group can be introduced to Annexin V.  For more information regarding SH-mediated conjugation of Annexin V please consult published papers such as this one.

Go To Top Version: 7    Revision Date: 10-22-2024

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account